Skip to main content
SpringerLink
Log in

Antineoplastics

Hypereosinophilic syndrome, colitis and lack of efficacy: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lazzari C, et al. Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies. Frontiers in Oncology 13: 26 Jan 2023. Available from: URL: http://www.frontiersin.org/Oncology/about

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1954, 50 (2023). https://doi.org/10.1007/s40278-023-37868-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37868-9

Search

Navigation